🇺🇸 FDA
Patent

US 11975003

Methods and compositions for treatment of Zika virus infection

granted A61KA61K31/519A61K45/06

Quick answer

US patent 11975003 (Methods and compositions for treatment of Zika virus infection) held by BioCryst Pharmaceuticals, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/519, A61K45/06, A61K9/0019, A61K9/0053